VitaSpring Biomedical Co. Ltd.
VSBC
$0.01
-$0.24-95.56%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.70% | -36.77% | 15.42% | -54.69% | -68.13% |
| Depreciation & Amortization | -- | 0.00% | 0.00% | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.70% | -36.05% | 15.10% | -54.69% | -68.13% |
| Operating Income | -9.70% | 36.05% | -15.10% | 54.69% | 68.13% |
| Income Before Tax | -9.70% | 35.57% | -15.10% | 54.69% | 68.13% |
| Income Tax Expenses | -- | -100.00% | -91.33% | -- | -- |
| Earnings from Continuing Operations | 5.84% | 43.05% | 27.41% | 49.34% | 62.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.84% | 43.05% | 27.41% | 49.34% | 62.87% |
| EBIT | -9.70% | 36.05% | -15.10% | 54.69% | 68.13% |
| EBITDA | -10.04% | 36.77% | -15.42% | 55.32% | 68.88% |
| EPS Basic | 0.00% | 42.86% | 22.22% | 54.55% | 60.00% |
| Normalized Basic EPS | 0.00% | 50.00% | 0.00% | 57.14% | 71.43% |
| EPS Diluted | 0.00% | 42.86% | 22.22% | 54.55% | 60.00% |
| Normalized Diluted EPS | 0.00% | 50.00% | 0.00% | 57.14% | 71.43% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |